Visit Blog
Order Online
Contact ZS
Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition; Gower Publishing) is the most comprehensive book on global pharmaceutical pricing available today. The book offers a thorough and straightforward exploration of the drug pricing process and includes Schoonveld’s insightful perspectives on how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process. All stakeholders – from healthcare professionals and policy makers to the broader public – can use the book to gain a better understanding of this highly complex and emotionally charged topic.
This second edition includes:
Ed Schoonveld is a Managing Principal at ZS Associates and is the leader of the firm’s Market Access and Pricing practice. In this role, he provides strategic consulting and research solutions to healthcare industry clients. He is considered to be one of the world’s leading experts on global pharmaceutical pricing and market access and has unparalleled experience as head of global market access and pricing functions at Wyeth, Lilly, and BMS, and as a consulting leader at Cambridge/IMS and a number of other organizations. You can learn more about Ed Schoonveld on Twitter and LinkedIn.
In this blog, Managing Principal Ed Schoonveld tackles the global drug pricing debate and provides commentaries on current events and issues in the payer environment.
Now available on Amazon Kindle, The Price of Global Health is the most comprehensive book on global pharmaceutical pricing available today.
ZS thought leaders Ed Schoonveld, Bill Coyle and Jennifer Markham publish their latest article in Clinical Therapeutics on the impact of ObamaCare on the pharma industry.
Managing Principal Ed Schoonveld’s latest article for pharmaphorum discusses how various approaches have been taken to try to _blankance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term.